Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ALPMY - Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?


ALPMY - Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals?

It is no secret that in the field of biotech, small- to mid-cap companies that develop innovative therapies for difficult-to-treat diseases (such as cancer) and a variety of rare conditions are often acquired by large-cap players for billions of dollars. Last year, the biggest ever biotech deal happened when Bristol Myers Squibb (NYSE: BMY) acquired Celgene for $74 billion. 

Today, let's take a look at a company that is at the forefront of battling chronic hepatitis B and has the potential to be acquired by its research and development partner. 

Image source: Getty Images.

Continue reading

Stock Information

Company Name: Astellas Pharma Inc. ADR
Stock Symbol: ALPMY
Market: OTC

Menu

ALPMY ALPMY Quote ALPMY Short ALPMY News ALPMY Articles ALPMY Message Board
Get ALPMY Alerts

News, Short Squeeze, Breakout and More Instantly...